Couple raise of funds, as all typical reverse take overs involve...

Couple raise of funds, as all typical reverse take overs involve , the first part being $500k they are currently raising, will be interesting to see the terms of that, i think over 1-1.2c is a good vote to the market people are not getting cheap stock after the news of the deal has been announced.

then there is the $3M for the business and growing the Epat business happening soon.

in the backdrop there is the current resource assets and is it going to be a off market sale with the cash perhaps strengthening the balance sheet and hence no diluting stock for future funding needs, or will it be a spin out and in specie distribution. After having a think about this I prefer the cash sale and put it in the bank, you know the company is going to needs funds to grow the Epat business, why not show the market it has a strong balance sheet to do so.

Interestingly i thought the market would get more excited with MNQ deal and certainly more people discuss on this website. This in my opinion is RAP 2 with only these two companies having a tech in the same type of space, not drinking out of the same glass but it is in the same pub. The success of RAP and the sustained success which i think is more important and its market cap of over $120M shows that MNQ has plenty of upside and represents great value currently. Perhaps as the weeks unfold and the newsflow about all of the above come out the market catches on and the demand follows which i believe it will.

evidence of RAP this week easily getting $10M in fact over subscribed they took $12M at 20c issue shows this health tech space is in demand!!!

looking for this to unfold like the RAP story of the last 4-6 months